Bill > HR3682

This bill, the Improving Transparency to Lower Drug Costs Act of 2021, amends the Social Security Act to provide greater transparency for discounts provided by drug manufacturers. The key provisions of the bill are: 1. It requires the Secretary of Health and Human Services to publicly disclose certain information on the Department's website, starting in 2022, regarding generic dispensing rates and information on rebates, discounts, fees, and price concessions negotiated by Pharmacy Benefit Managers (PBMs) with drug manufacturers. 2. The disclosure of this information must be done in a way that prevents the disclosure of sensitive, proprietary information about individual drugs or plans. The information will be made available by drug class, using an existing classification system, with a minimum number of drugs in each class to ensure confidentiality. The goal of this bill is to increase transparency around the negotiated discounts and fees in the drug supply chain, which policymakers believe will help lower drug costs for consumers.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/3682/all-info